FMC director gains 306 shares via stock dividend
FMC Corporation director Robert C. Pallash received additional equity compensation in the form of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
FMC Corporation director Robert C. Pallash received additional equity compensation in the form of common stock. On January 15, 2026, he acquired 306 shares of FMC common stock at a price of $0.00 per share through dividend equivalent rights connected to vested restricted stock units held by him. After this transaction, he directly beneficially owned 60,422 FMC common shares. This was a Form 4 filing by a single reporting person in his capacity as a director, reflecting a routine equity-based compensation accrual rather than an open‑market trade.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 306 | $0.00 | $0.00 |
Footnotes (1)
- F1. These shares were issued pursuant to dividend equivalent rights in connection with vested restricted stock units held by the reporting person.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did FMC (FMC) report for Robert C. Pallash?
Is this FMC (FMC) Form 4 transaction an open‑market purchase or sale?
What is Robert C. Pallash’s relationship to FMC (FMC)?
AI-generated analysis. How Rhea-AI works. Not financial advice.